Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells

Author： Du Wei Pang Changhe Xue Yake Zhang Qingjun Wei Xinting

E-ISSN： 1792-1082|10|5|3266-3270

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.5, 2015-11, pp. : 3266-3270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1571-1580

Spandidos Publications

Access to resources Recommend Favorite

Tenuifoliside A promotes neurite outgrowth in PC12 cells via the PI3K/AKT and MEK/ERK/CREB signaling pathways

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7637-7642

Spandidos Publications

Access to resources Recommend Favorite

Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 1113-1119

Spandidos Publications

Access to resources Recommend Favorite

Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells

By Thant Aye Nawa Akihiro Kikkawa Fumitaka Ichigotani Yasukatu Zhang Yangying Sein Thet Amin A.R.M. Hamaguchi Michinari

Clinical and Experimental Metastasis, Vol. 18, Iss. 5, 2000-09 ,pp. : 423-428

Springer Publishing Company

Access to resources Recommend Favorite

Recent Developments in Targeted Therapies of the RAF-MEK and PI3KAKT Pathways in Cancer Treatment

Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-01 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite